127 related articles for article (PubMed ID: 35973832)
1. Myocardium-Targeted Micelle Nanomedicine That Salvages the Heart from Ischemia/Reperfusion Injury.
Yang L; Peng J; Shi A; Wang X; Li J; Su Y; Yin K; Zhao L; Zhao Y
ACS Appl Mater Interfaces; 2022 Aug; 14(34):38562-38574. PubMed ID: 35973832
[TBL] [Abstract][Full Text] [Related]
2. Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles.
Galagudza M; Korolev D; Postnov V; Naumisheva E; Grigorova Y; Uskov I; Shlyakhto E
Int J Nanomedicine; 2012; 7():1671-8. PubMed ID: 22619519
[TBL] [Abstract][Full Text] [Related]
3. A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model.
Ichimura K; Matoba T; Nakano K; Tokutome M; Honda K; Koga J; Egashira K
PLoS One; 2016; 11(9):e0162425. PubMed ID: 27603665
[TBL] [Abstract][Full Text] [Related]
4. Multiple delivery strategies of nanocarriers for myocardial ischemia-reperfusion injury: current strategies and future prospective.
Li S; Li F; Wang Y; Li W; Wu J; Hu X; Tang T; Liu X
Drug Deliv; 2024 Dec; 31(1):2298514. PubMed ID: 38147501
[TBL] [Abstract][Full Text] [Related]
5. Local delivery of a senolytic drug in ischemia and reperfusion-injured heart attenuates cardiac remodeling and restores impaired cardiac function.
Lee JR; Park BW; Park JH; Lim S; Kwon SP; Hwang JW; Kim H; Park HJ; Kim BS
Acta Biomater; 2021 Nov; 135():520-533. PubMed ID: 34454081
[TBL] [Abstract][Full Text] [Related]
6. Effect of isoflurane on myocardial ischemia-reperfusion injury through the p38 MAPK signaling pathway.
Zhou Y; Peng DD; Chong H; Zheng SQ; Zhu F; Wang G
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1342-1349. PubMed ID: 30779102
[TBL] [Abstract][Full Text] [Related]
7. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
[TBL] [Abstract][Full Text] [Related]
8. Human Recombinant Apyrase Therapy Protects Against Myocardial Ischemia/Reperfusion Injury and Preserves Left Ventricular Systolic Function in Rats, as Evaluated by 7T Cardiovascular Magnetic Resonance Imaging.
Xu Z; Chen W; Zhang R; Wang L; Chen R; Zheng J; Gao F
Korean J Radiol; 2020 Jun; 21(6):647-659. PubMed ID: 32410404
[TBL] [Abstract][Full Text] [Related]
9. Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction.
Thummasorn S; Apaijai N; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Cardiovasc Ther; 2016 Dec; 34(6):404-414. PubMed ID: 27434747
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats.
Zhang CX; Cheng Y; Liu DZ; Liu M; Cui H; Zhang BL; Mei QB; Zhou SY
J Nanobiotechnology; 2019 Jan; 17(1):18. PubMed ID: 30683110
[TBL] [Abstract][Full Text] [Related]
11. Treatment with cardiotonic pills(®) after ischemia-reperfusion ameliorates myocardial fibrosis in rats.
Wei XH; Liu YY; Li Q; Yan L; Hu BH; Pan CS; Li ZX; Chang X; Fan JY; Zhao N; Sun K; Huang P; Wang CS; Fan TP; Han JY
Microcirculation; 2013 Jan; 20(1):17-29. PubMed ID: 22913380
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin infusion during ischemia/reperfusion attenuates left ventricular remodeling and myocardial fibrosis in rats.
Okumura H; Nagaya N; Kangawa K
Hypertens Res; 2003 Feb; 26 Suppl():S99-104. PubMed ID: 12630818
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart.
Obana M; Miyamoto K; Murasawa S; Iwakura T; Hayama A; Yamashita T; Shiragaki M; Kumagai S; Miyawaki A; Takewaki K; Matsumiya G; Maeda M; Yoshiyama M; Nakayama H; Fujio Y
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H569-77. PubMed ID: 22707562
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1.
Chen H; Li D; Saldeen T; Mehta JL
Am J Physiol Heart Circ Physiol; 2003 May; 284(5):H1612-7. PubMed ID: 12679326
[TBL] [Abstract][Full Text] [Related]
16. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.
Nagaoka K; Matoba T; Mao Y; Nakano Y; Ikeda G; Egusa S; Tokutome M; Nagahama R; Nakano K; Sunagawa K; Egashira K
PLoS One; 2015; 10(7):e0132451. PubMed ID: 26167913
[TBL] [Abstract][Full Text] [Related]
17. Modified VEGF targets the ischemic myocardium and promotes functional recovery after myocardial infarction.
Yang Y; Shi C; Hou X; Zhao Y; Chen B; Tan B; Deng Z; Li Q; Liu J; Xiao Z; Miao Q; Dai J
J Control Release; 2015 Sep; 213():27-35. PubMed ID: 26144351
[TBL] [Abstract][Full Text] [Related]
18. Remifentanil post-conditioning attenuates cardiac ischemia-reperfusion injury via kappa or delta opioid receptor activation.
Wong GT; Li R; Jiang LL; Irwin MG
Acta Anaesthesiol Scand; 2010 Apr; 54(4):510-8. PubMed ID: 19878098
[TBL] [Abstract][Full Text] [Related]
19. A Model of Blood Component-Heart Interaction in Cardiac Ischemia-Reperfusion Injury using a Langendorff-Based Ex Vivo Assay.
Muessig JM; Kaya S; Moellhoff L; Noelle J; Hidalgo Pareja L; Masyuk M; Gerdes N; Pernow J; Kelm M; Jung C
J Cardiovasc Pharmacol Ther; 2020 Mar; 25(2):164-173. PubMed ID: 31495204
[TBL] [Abstract][Full Text] [Related]
20. Exogenous GDF11 attenuates non-canonical TGF-β signaling to protect the heart from acute myocardial ischemia-reperfusion injury.
Su HH; Liao JM; Wang YH; Chen KM; Lin CW; Lee IH; Li YJ; Huang JY; Tsai SK; Yen JC; Huang SS
Basic Res Cardiol; 2019 Mar; 114(3):20. PubMed ID: 30900023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
